secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kymera Therapeutics, Inc. (KYMR)
CIK:        0001815442
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001193125-23-067797
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Kymera reports limited SVB exposure of $2.2M cash and $4.5M letter of credit
----------------------------------------------------------------------------

- As of March 10, 2023, Kymera holds $2.2M cash at Silicon Valley Bank (SVB) and $4.5M restricted cash letter of credit.
- Total cash and equivalents reported at $560M as of Dec 31, 2022; SVB exposure represents <1% of cash.
- Company does not anticipate any material impact on operations or liquidity from SVB closure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815442/000119312523067797/0001193125-23-067797-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815442/000119312523067797/d459968d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-067797

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer